Modeling the impacts of restrictive formularies on patients with HIV. [electronic resource]
- The American journal of managed care 07 2018
- SP322-SP328 p. digital
Anti-HIV Agents--economics Cause of Death Cohort Studies Disease Progression Disease-Free Survival Drug Therapy, Combination Female HIV Infections--diagnosis Humans Male Managed Care Programs--economics Models, Educational Prognosis Risk Assessment Survival Analysis Time Factors Treatment Failure Treatment Outcome United States